Thus, SIL could conceivably be divided into two groups, one group comprises SIL without elevated MIP-1α and who do not possess acute inflammation, while the other group comprises SIL with higher MIP-1α and who may still possess active inflammatory lesions in their pulmonary lesions. The gene discussed is CCL3; the disease is squamous cell intraepithelial neoplasia.